Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01976260 · ClinicalTrials.gov registry record · Phase 2
A Pilot Study Testing Fractional Radiofrequency Versus Fractional Photothermolysis for the Treatment of Acne Scars
A Phase 2 study of Cicatrix, sponsored by Northwestern University.
- Active
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT01976260: Active Phase 2 study of Cicatrix, sponsored by Northwestern University.
NCT01976260 is a Phase 2 study of Cicatrix that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 16 participants, below the 34-participant average among 4 other Cicatrix trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01976260, a Phase 2 study of Cicatrix, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the effectiveness of the ePrime fractional radiofrequency system to the 1550-nm fractional photothermolysis system (Fraxel) in the ability to improve acne scar appearance.
Primary Outcome
The primary outcome was a blinded rating of the treatment area (Fractional Radiofrequency Versus Fractional Photothermolysis) with the best cosmetic appearance. A dermatologist will blindly evaluate the treated areas of each side from live subjects at baseline and on the final follow up visit (week 16).
Conditions Studied
Interventions
- DEVICE Fractional Radiofrequency
- DEVICE 1550-nm Fractional Photothermolysis
Study Locations (1)
Illinois
- Northwestern University Department of Dermatology - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2013-10 |
| Est. Completion | 2025-12 |
| Phase | Phase 2 |
What the registry record for NCT01976260 still lists
NCT01976260 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 34-participant average among 4 other Cicatrix trials with a reported enrollment target (53% lower).
The record links to 1 condition, with Cicatrix appearing as the primary indexed condition, and to 2 interventions - of which Fractional Radiofrequency is the first listed.
NCT01976260 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT01976260 about?
NCT01976260 is a clinical study titled "A Pilot Study Testing Fractional Radiofrequency Versus Fractional Photothermolysis for the Treatment of Acne Scars". The purpose of this study is to compare the effectiveness of the ePrime fractional radiofrequency system to the 1550-nm fractional photothermolysis system (Fraxel) in the ability to improve acne scar appearance.
What is the current status of trial NCT01976260?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2013-10. Estimated completion is 2025-12.
What conditions does trial NCT01976260 study?
This clinical trial studies the following conditions: Cicatrix.
What interventions are being tested in trial NCT01976260?
The interventions under investigation include: Fractional Radiofrequency (DEVICE), 1550-nm Fractional Photothermolysis (DEVICE).
Who is sponsoring clinical trial NCT01976260?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01976260 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cicatrix
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treatment of Hypopigmented Scars With Bimatoprost
RECRUITING · Phase 2
-
Abdominal Scar Improvement in Microsurgical Breast Reconstruction
ACTIVE NOT RECRUITING · NA
-
Laser Resurfacing Versus Dermabrasion for Scar Revision
COMPLETED · NA
-
"A Clinical Study Investigating the Effectiveness of OTC Scar-management Modalities"
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia